Dokumentumok
KPS PONT
Label: obesity
FDA Issues Early Communication about Ongoing Safety Review of Weight Loss Drug Orlistat
The U.S. Food and Drug Administration announced today that it is reviewing adverse event reports of liver injury in patients taking the weight loss drug orlistat, marketed as the prescription drug Xenical and the over-the-counter medication More»
Impact of Obesity on Bowel Preparation for Colonoscopy
Background & Aims: An inadequately cleansed colon can lead to missed lesions, repeat procedures, increased cost, and complications from colonoscopy. Because obesity, with its known link to colorectal neoplasia, might be associated More»
Upper Gastrointestinal Symptoms and Associated Disorders in Morbidly Obese Patients: A Prospective S
Objective To prospectively evaluate the frequency of upper gastrointestinal symptoms and associated disorders in morbidly obese patients with endoscopy and histology prior to their gastric bypass surgery in comparison with age- and More»
